New Jersey. Contact Information. Statistics. Technological Capabilities

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "New Jersey. Contact Information. Statistics. Technological Capabilities"

Transcription

1 PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Mielo, James - Administrator 124 Halsey St Newark NJ Office: (973) Fax: NJPMRS ASAP Versions Accepted ASAP 1995 ASAP 1997 ASAP 3/2005 New Jersey Department of Law and Public Safety, Division of Consumer Affairs Law Enforcement Agency ASAP 4/2007 ASAP 4-1/2010 ASAP 4-2/2011 Pharmacy in-state Pharmacy out-state/mail order Pharmacy out-state other Dispensing doctor Contact Information Rosen, Eric Halsey St Newark NJ Office: (973) Fax: Technological Capabilities Electronic data transmissio Fax data transmission Mail data transmission Media data transmission Required Data Transmitters Veterinarian Veterans Administration Indian Health Services Data Transmission Methods Allowed Other data transmission Other: Data Collection Entity: Vendor Vendor name: Optimum Technology Data Storage Entity: Vendor Vendor name: Optimum Technology Report Generation Entity: Vendor Vendor name: Optimum Technology Data Access Method: Web Portal/On-Line Statistics Data Collection, Storage, Generation and Access Data Access Entity: Vendor Vendor name: Optimum Technology PDMP region: Statistics Year: 2014 DEA Registered Prescribers: 45,359 State population: 8,938,175 DEA Registered Dispensers: 2,093 East

2 Interstate data sharing PMPi Hub RxCheck Hub RxSentry Hub HIE method Other Hub Data Access via Health Information Exchang via Electronic Health Recor via Pharmacy Dispensing Syste Controlled Schedules Monitored Schedule II monitored Schedule III monitored Schedule IV monitored Schedule V monitored Data Collection and Dates Collection frequency: 1 Legislation enacted: PDMP operational Data Sharing List of states involved in sharing: CT, DE, MN, RI, VA Impediments to data sharing: MOU Signed with CT. Currently awaiting vendor configuration of PMPi Hub interface. Anticipate sharing to begin in April Patient Matching Exact Match Probablistic/Manual Matc Probablistic Match Other Match for queries If probalistic match does not provide certainty of a match, request is forwarded to system administrator for final selection Policies and Procedures Monitor other authority Human Growth hormones Remove from Monitoring Web 24/7 Fax 24/7 Web Business Hours Fax Business Hours Other Other Substances Monitored Data Request Methods and Hours of Operation Phone Business Hours Business Hours Mail Business Hours In-Person Business Hours Other Relevant Statutes and Rules Law/Rule Website: Law/Statute citation: NJ Statute 45: 1-45 to 1-52; 24:21-54 Regulation/Rule citation: Dr Shopper law/statute: Pill Mill law/statute: Pain Clinic law/statute: Disclosure law/statute: NJ Statute 45: 1-49(b) Data Retention Policy All Information Purged Data Retention Time: Record Retention Details: De-Identified Data Retention Details: Prescriber Information Purged Dispenser Information Purged Data Retention Patient Information Purged Drug Information Purged Retain De-Identified Data

3 Required Enrollment - Prescriber Required Enrollment - Dispenser PDMP Required Enrollment and Patient Query Required Patient Query - Prescriber Required Patient Query - Dispenser Required PDMP Enrollment and/or PDMP Query Detai requires physicians and pharmacists to check PDMP before prescribing/dispensing controlled substance and every 3 months thereafter. Select Data Fields Available Payment method captured Patient Identification captured Person dropping off captured Person picking up captured Ability to id prescriber specialty Prescriber: Dispenser: Miscellaneous Capabilities and Policies Authority to release de-identified data Ability to de-identified data Authority to release for epidemiological or educational purposes Engaged in release for epidemiological or educational purposes Required Notification to consumers Mandated Use of Advisory Group Patient Access to Query List Requirements to Query PDMP To register, DEA Registration number (required for certain user types), state license number (required) and NPI (If available). Regulatory Board: Regulatory Board can query by certification of investigation Law Enforcement: Law Enforcement/ Attorney General can query via grand jury subpoena and officer's certification. Attorney General: Law Enforcement/ Attorney General can query via grand jury subpoena and officer's certification. Researcher: Patient: Other: Prescriber Access to Patient History Prescriber Access to Own History Dispenser Access to Patient History Dispenser Access to Own History PDMP Available Reports Available Reports to Selected Requestors Licensing Board Access to Patient History Licensing Board Access to Licensee History Law Enforcement Access to Patient History Law Enforcement Access to Prescriber History Law Enforcement Access to Dispenser History

4 Requestors and Reports Authorized to Generate Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Medical Examiner/Coroner Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State

5 Requestors and Reports Being Generated Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Medical Examiner/Coroner Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department

More information

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: rhiggins@gdna.ga.gov

More information

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc.

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc. PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Frick, Christie J. - Director (Rph) 2600 Bull St Columbia SC 29201 Office: (803) 896-0688 Fax: (803) 896-0686 Email: SCRIPTS frickcj@dhec.sc.gov

More information

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Berberet, Craig - PMP Manager 401 N Fourth St, Rm 126 Springfield IL 62702 Office: (217) 558-0943 Fax: (217) 557-7975 Email: PIL Department

More information

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net pmp@bop.idaho.gov Anderson, Teresa - Program Information Coordinator

More information

Colorado. Contact Information. Statistics. Technological Capabilities

Colorado. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Colorado State Board of Pharmacy Pharmacy Board http://www.hidinc.com/copdmp pdmpinqr@state.co.us Rivera, Janina - PDMP Administrator

More information

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -

More information

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Florida Department of Health Department of Health Florida http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov

More information

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Arizona State Board of Pharmacy Pharmacy Board Wright, Dean - Program Director P O Box 18520 Phoenix AZ 85005 Office: (602) 771-2744

More information

Washington. Contact Information. Email: Statistics. Technological Capabilities

Washington. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington

More information

Montana. Contact Information. Email: Statistics. Technological Capabilities

Montana. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Montana Board of Pharmacy Pharmacy Board www.mpdr.mt.gov dlibsdmpdr@mt.gov Peterson, Donna - Program Manager PO Box 200513 Helena MT

More information

New Mexico. Contact Information. Email: Statistics. Technological Capabilities

New Mexico. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us

More information

Massachusetts. Contact Information. Statistics. Technological Capabilities

Massachusetts. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted

More information

Guam. Contact Information. Email: Statistics. Technological Capabilities

Guam. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Naval, Cynthia L. - Planner IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7204 Fax: (671) 734-5556 Email: GPDMP Guam

More information

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace

More information

Alaska Prescription Drug Monitoring Program

Alaska Prescription Drug Monitoring Program Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this

More information

COMPILATION OF STATE PRESCRIPTION MONITORING PROGRAM MAPS

COMPILATION OF STATE PRESCRIPTION MONITORING PROGRAM MAPS MTION OF STATE PREPTION NITONG PROGRAM PS This project was supported by Cooperative Agreement No. 202-DC-BX-K002 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS 2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement 2013 Telephone: (781) 609-7741 Fax: (888) 705-8053 Email: info@pdmpassist.org Website: www.pdmpassist.org INTRODUCTION

More information

FACT SHEET FOR HEALTH CARE PRACTITIONERS

FACT SHEET FOR HEALTH CARE PRACTITIONERS Florida s Prescription Drug Monitoring Program http://www.e-forcse.com FACT SHEET FOR HEALTH CARE PRACTITIONERS The Florida Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic- Florida

More information

The Administration s Response to the Prescription Drug Epidemic: Action Items

The Administration s Response to the Prescription Drug Epidemic: Action Items The Administration s Response to the Prescription Drug Epidemic: Action Items As outlined in Epidemic: Responding to America s Prescription Drug Abuse Crisis, below are the action items identified in the

More information

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics

More information

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as

More information

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform Recommendations of the Committee on Workers Compensation and Personal Injury and The Special Advisers on Prescription Drug Abuse Approved by the CMS House of Delegates September 21, 2013 The Public Health

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

A New Generation of Prescription Monitoring Programs: Best & Promising Practices

A New Generation of Prescription Monitoring Programs: Best & Promising Practices A New Generation of Prescription Monitoring Programs: Best & Promising Practices National PDMP Meeting Washington, DC September 25, 2013 Presented by John L Eadie Why Is a New Generation of PDMPs Being

More information

Harold Rogers Prescription Drug Monitoring Program

Harold Rogers Prescription Drug Monitoring Program Harold Rogers Prescription Drug Monitoring Program 19 th National Conference on Pharmaceutical and Chemical Diversion June 16-17, 2010 Harold Rogers Prescription Drug Monitoring Program Since fiscal year

More information

Prescription Drug Monitoring Programs Bill Status Update

Prescription Drug Monitoring Programs Bill Status Update Prescription Drug Monitoring Programs Bill Status Update Research current through February 24, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control

More information

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Jeanne Tuttle, R.Ph. National Pharmacist Program Managers Pharmacy Benefits Management Services

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

2010-2011 Prescription Drug Monitoring Program Annual Report

2010-2011 Prescription Drug Monitoring Program Annual Report 2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription

More information

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs PDMP Training and Technical Assistance Center Brandeis University History of Prescription Drug Monitoring Programs First PDMP Early PDMP Characteristics

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Prescribers required to check PDMP before first prescription for Controled Substances for new patient. State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,

More information

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PART 1: STATE PRESCRIPTION DRUG MONITORING PROGRAMS (PMPS) PREPARED BY THE NATIONAL

More information

DEA's New Proposed Regulations For E-Prescribing

DEA's New Proposed Regulations For E-Prescribing Portfolio Media, Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 customerservice@portfoliomedia.com DEA's New Proposed Regulations For E-Prescribing

More information

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following: Section XX. Definitions. Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended (1) by striking clause (ii) and inserting the following: (ii) The term qualifying practitioner

More information

SUBSTITUTE FOR HOUSE BILL NO. 5326

SUBSTITUTE FOR HOUSE BILL NO. 5326 SUBSTITUTE FOR HOUSE BILL NO. 5326 A bill to amend 1978 PA 368, entitled "Public health code," by amending sections 7333a, 7422, 17708, and 17757 (MCL 333.7333a, 333.7422, 333.17708, and 333.17757), section

More information

The Massachusetts Prescription Monitoring Program

The Massachusetts Prescription Monitoring Program The Massachusetts Prescription Monitoring Program A Report to the Massachusetts General Court February 2015 Governor Charles D. Baker Secretary of Health and Human Services Marylou Sudders Massachusetts

More information

SENATE, No. 2729 STATE OF NEW JERSEY 216th LEGISLATURE

SENATE, No. 2729 STATE OF NEW JERSEY 216th LEGISLATURE LEGISLATIVE FISCAL ESTIMATE SENATE, No. 2729 STATE OF NEW JERSEY 216th LEGISLATURE DATED: MAY 12, 2015 SUMMARY Synopsis: Type of Impact: Agencies Affected: Authorizes health care practitioners to provide

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate

More information

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.

More information

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010 Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an

More information

Prescription Monitoring Programs: Creating a National Network

Prescription Monitoring Programs: Creating a National Network Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison ddroz@nabp.net 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical

More information

Training Guide for Florida Practitioners and Pharmacists. Florida Department of Health Prescription Drug Monitoring Program

Training Guide for Florida Practitioners and Pharmacists. Florida Department of Health Prescription Drug Monitoring Program Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program January 2015 Contents Contents 1 Program Overview... 2 2 Document Overview...

More information

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of

More information

New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward

New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward New Jersey State Legislative Update Opioid Addiction and Abuse Prevention Legislative Package Moves Forward By Laurie A. Clark NJSIPP Legislative Counsel May 12, 2015 The New Jersey Legislature is currently

More information

Manual of Instructions

Manual of Instructions NEW YORK STATE DEPARTMENT OF HEALTH OFFICIAL NEW YORK STATE PRESCRIPTION PROGRAM ELECTRONIC DATA TRANSMISSION Manual of Instructions New York State Department of Health Bureau of Narcotic Enforcement 433

More information

PDMP and HIE Integration: The Maryland Experience

PDMP and HIE Integration: The Maryland Experience PDMP and HIE Integration: The Maryland Experience January 14, 2015 Kate Jackson Maryland PDMP Manager Lindsey Ferris CRISP PDMP Project Manager Background on CRISP What is CRISP? CRISP is a non-profit

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN) Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers

More information

Technical Assistance Guide No. 04-13 Funding Options for Prescription Drug Monitoring Programs

Technical Assistance Guide No. 04-13 Funding Options for Prescription Drug Monitoring Programs Technical Assistance Guide No. 04-13 Funding Options for Prescription Drug Monitoring Programs July 3, 2013 Introduction Over the past ten years, prescription drug monitoring programs (PDMPs) have proliferated

More information

Medicare Compliance and Fraud, Waste, and Abuse Training

Medicare Compliance and Fraud, Waste, and Abuse Training Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques

More information

Second Annual Florida 2008 Electronic Prescribing Report

Second Annual Florida 2008 Electronic Prescribing Report Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians

More information

Pennsylvania s ABC-MAP Program

Pennsylvania s ABC-MAP Program Pennsylvania s ABC-MAP Program Recommendations on Best Practices ABC-MAP Governance Board Meeting May 20, 2015 Brandon C. Maughan, MD, MHS Marcus A. Bachhuber, MD University of Pennsylvania Philadelphia

More information

NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP)

NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP) NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP) DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 NJRxReport@otech.com Fax: 866-282-7076

More information

TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM

TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM Section 1. Authority 8-1 Section 2. Transmission of Information Regarding Dispensing of Controlled Substances to Certain Persons 8-1 Section

More information

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances American Society of Health-System Pharmacists 7272 Wisconsin Avenue Bethesda, Maryland 20814 (301) 657-3000 Fax: (301) 664-8877 www.ashp.org Drug Enforcement Administration Attention: DEA Federal Register

More information

CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:

CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows: CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.

More information

Review of Prescription Drug Monitoring Programs in the United States

Review of Prescription Drug Monitoring Programs in the United States Review of Prescription Drug Monitoring Programs in the United States Kentucky All Schedule Prescription Electronic Reporting Program (KASPER) Evaluation Team* Institute for Pharmaceutical Outcomes and

More information

PRESCRIPTION MONITORING PROGRAM (PMP)

PRESCRIPTION MONITORING PROGRAM (PMP) PRESCRIPTION MONITORING PROGRAM (PMP) DATA REPORTING MANUAL Effective Date: April 1, 2012 Contact Information: (505) 222-9830 larry.loring@state.nm.us 1 P a g e Table of Contents Reporting requirements

More information

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director

More information

Training Guide for Florida Practitioners and Pharmacists

Training Guide for Florida Practitioners and Pharmacists Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program March 2014 Note This document is periodically updated. Please refer to the Florida

More information

Prescription Drug Monitoring Program. A Powerful Tool

Prescription Drug Monitoring Program. A Powerful Tool Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5) HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care

More information

American Indian Health Commission for Washington State October 1, 2015

American Indian Health Commission for Washington State October 1, 2015 American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.

More information

Fraud, Waste & Abuse. Training Course for UHCG Employees

Fraud, Waste & Abuse. Training Course for UHCG Employees Fraud, Waste & Abuse Training Course for UHCG Employees Overview The Centers for Medicare & Medicaid Services (CMS) require Medicare Advantage Organizations and Part D Plan Sponsors to provide annual fraud,

More information

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System 0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill

More information

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj. PLEASE READ The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.us/ New Jersey Statutes Annotated (N.J.S.A.), published by

More information

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity Technical Assistance Guide PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity This project was supported by Grant No. 2011-PM-BX-K001 awarded by the Bureau of Justice Assistance.

More information

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

Fraud Waste and Abuse Training Requirement. To Whom It May Concern: RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)

More information

HIPAA POLICY USING, DISCLOSING, AND REQUESTING THE MINIMUM NECESSARY AMOUNT OF PROTECTED HEALTH INFORMATION

HIPAA POLICY USING, DISCLOSING, AND REQUESTING THE MINIMUM NECESSARY AMOUNT OF PROTECTED HEALTH INFORMATION HIPAA POLICY POLICY: USING, DISCLOSING, AND REQUESTING THE MINIMUM NECESSARY AMOUNT OF PROTECTED HEALTH INFORMATION POLICY NUMBER: 2023 APPLICABLE FACILITIES: MCH, MCS, PCC DATE EFFECTIVE: APRIL 14, 2003

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: August 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Enhancing Access to Prescription Drug Monitoring Programs Using Health Information Technology: Work Group Recommendations

Enhancing Access to Prescription Drug Monitoring Programs Using Health Information Technology: Work Group Recommendations Prepared for Office of the National Coordinator for Health Information Technology, in partnership with the Substance Abuse and Mental Health Services Administration Enhancing Access to Prescription Drug

More information

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related entities

More information

Prescription Drug Abuse Florida s Health Crisis

Prescription Drug Abuse Florida s Health Crisis Prescription Drug Abuse Florida s Health Crisis Overview Florida has been the epicenter for the diversion and abuse of prescription drugs. Prescription drugs killed almost 7 Floridians per day after an

More information

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1381 Prescription Drug Monitoring Program SPONSOR(S): Davis TIED BILLS: IDEN./SIM. BILLS: REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF

More information

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that

More information

SCOPE OF PRACTICE FOR ARNPS

SCOPE OF PRACTICE FOR ARNPS FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow

More information

PMP AWAR X E. User Support Manual V 1.2

PMP AWAR X E. User Support Manual V 1.2 PMP AWAR X E User Support Manual V 1.2 04/09/2014 1 Contents 1 What Is a Requestor?... 3 2 Registration... 3 2.1 Registration Process... 3 2.2 Registering as a Delegate... 7 2.3 Email Verification... 11

More information

GENERAL INFORMATION: NURSE PRACTITIONER PRACTICE

GENERAL INFORMATION: NURSE PRACTITIONER PRACTICE BUSINESS, CONSUMER SERVICES, AND HOUSING AGENCY GOVERNOR EDMUND G. BROWN JR. BOARD OF REGISTERED NURSING PO Box 944210, Sacramento, CA 94244-2100 P (916) 322-3350 F (916) 574-8637 www.rn.ca.gov Louise

More information

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority: Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain

More information

K-TRACS KANSAS TRACKING AND REPORTING OF CONTROLLED SUBSTANCES

K-TRACS KANSAS TRACKING AND REPORTING OF CONTROLLED SUBSTANCES K-TRACS KANSAS TRACKING AND REPORTING OF CONTROLLED SUBSTANCES K-TRACS History and Integration Initiatives Marty Singleton Assistant Director Kansas State Board of Pharmacy 800 SW Jackson, Ste. 1414 Topeka,

More information

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015 Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement

More information

Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations

Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup healthvermont.gov dps.vermont.gov Executive Summary In 2008 the Prescription Drug

More information

VIRGINIA DEPARTMENT OF HEALTH PROFESSIONS VIRGINIA PRESCRIPTION MONITORING PROGRAM MINUTES OF ADVISORY PANEL

VIRGINIA DEPARTMENT OF HEALTH PROFESSIONS VIRGINIA PRESCRIPTION MONITORING PROGRAM MINUTES OF ADVISORY PANEL DRAFT VIRGINIA DEPARTMENT OF HEALTH PROFESSIONS VIRGINIA PRESCRIPTION MONITORING PROGRAM MINUTES OF ADVISORY PANEL Wednesday, September 30, 2015 9960 Mayland Drive, Suite 300 Henrico, Virginia 23233-1463

More information

MA Prescription Monitoring Program Prescriber Electronic Alert Notifications

MA Prescription Monitoring Program Prescriber Electronic Alert Notifications MA Prescription Monitoring Program Prescriber Electronic Alert Notifications Bureau of Health Care Safety and Quality Len Young, Epidemiologist February 20, 2014 Slide 1 MA PRESCRIPTION MONITORING PROGRAM

More information

VERMONT2008 Vermont Prescription Monitoring Program

VERMONT2008 Vermont Prescription Monitoring Program VERMONT2008 Vermont Prescription Monitoring Program Report to the Legislature on Act 205 January 15, 2009 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.863.7341 healthvermont.gov Vermont Prescription

More information

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances, Interim Final Rule with Request for Comment

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances, Interim Final Rule with Request for Comment American Society of Health-System Pharmacists 7272 Wisconsin Avenue Bethesda, Maryland 20814 (301) 657-3000 Fax: (301) 664-8877 www.ashp.org Drug Enforcement Administration Attention: DEA Federal Register

More information

NCPDP Electronic Prescribing Standards

NCPDP Electronic Prescribing Standards NCPDP Electronic Prescribing Standards September 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health

More information

1 st Tier & Downstream Training Focus

1 st Tier & Downstream Training Focus Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste

More information

Electronic Prescribing In New York State

Electronic Prescribing In New York State Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe

More information

VERMONT2007. Vermont Prescription Monitoring Program. Report to the Legislature on Act 205 January 15, 2008

VERMONT2007. Vermont Prescription Monitoring Program. Report to the Legislature on Act 205 January 15, 2008 VERMONT2007 Vermont Prescription Monitoring Program Report to the Legislature on Act 205 January 15, 2008 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.863.7341 healthvermont.gov Vermont Prescription

More information

UPDATED. Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs

UPDATED. Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs UPDATED Special Advisory Bulletin on the Effect of Exclusion from Participation in Federal Health Care Programs Issued May 8, 2013 Updated Special Advisory Bulletin on the Effect of Exclusion from Participation

More information